References
- 1. Veronesi U, Paganelli G. T, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997; 349: 1864-1867.10.1016/S0140-6736(97)01004-0
- 2. Kuehn T, Bembenek A, Decker T, Munz D. L, Sautter- Bihl ML, Untch M, Wallwiener D. Consensus Committee of the German Society of Senology. Cancer. 2005; 103: 451-461.10.1002/cncr.20786
- 3. Intra M, Garcia-Etienne C. A, Renne G, Trifro G, Rotmensz N, Gentillini O. D, et al. When sentinel lymph node is intramammary. Ann Surg Oncol. 2008; 15: 1304-1308.10.1245/s10434-007-9720-1
- 4. Hogan B. V, Peter M. B, Shenoy H, Horgan K, Shaaban A. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients. Surg Oncol. 2010; 19: 11-16.10.1016/j.suronc.2008.12.009
- 5. Shen J, Hunt K. K, Mirza N. Q, Krishnamurthy S, Singletary S. E, Kuerer H. M, et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast cancer. Cancer. 2004; 101: 1330-1337.10.1002/cncr.20515
- 6. Cody H. S, Urban J. A. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995; 2: 32-37.10.1007/BF02303699
- 7. Caceres E. Incidence of metastasis in the internal mammary chain in operable cancer of the breast. Surg Gynaecol Obstet. 1959; 108: 715-720.
- 8. Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten-year results of an international cooperative trial in breast cancer. Cancer. 1983; 51: 1941-1943.10.1002/1097-0142(19830515)51:10<1941::AID-CNCR2820511032>3.0.CO;2-T
- 9. Donegan W. L. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977; 39: 533-538.10.1002/1097-0142(197702)39:2<533::AID-CNCR2820390222>3.0.CO;2-V
- 10. Morrow M, Foster R. S, Jr. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg. 1981; 116: 748-751.10.1001/archsurg.1981.01380180012003
- 11. Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983; 198: 681-684.10.1097/00000658-198312000-00002
- 12. Guth A. A, Mercado C, Roses D. F, Hiotis K, Skinner K, Diflo T. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node? Am J Surg. 2006; 192: 502-505.
- 13. Fred W. C. van der Ent, Roland A. M. Kengen, Harry A.G. van der Pol, Joris A. C. M. Povel, et al. Halsted Revisited: Internal Mammary Sentinel Lymph Node biopsy in breast cancer. Ann Surg. 2001; Vol. 234(1): 79-84.10.1097/00000658-200107000-00012
- 14. Kijima Y, Yohinaka H, Uenosono Y, Funasako Y, Ehi K, Yanagita S, et al. Intramammary sentinel lymph node in patients with breast cancer: Report of four cases. Surg Today. 2008; 38: 536-540.10.1007/s00595-007-3660-z
- 15. Mathelin C, Tomasetto C, Rio M. C, Chenard M. P, Brettes J. P, Guyonnet J. L. Improvement in intramammary sentinel lymph node removal using a novel prototype hand held probe during breast conservative surgery. Breast Cancer Res Treat. 2005; 89: 305-308.10.1007/s10549-004-2128-8
- 16. Tytle I, Hayes A, Kissin M. Intramammary sentinel lymph nodes in early breast cancer: can we find them and do they matter? Eur J Surg Oncol. 2003; 29: 6-8.
- 17. Gajdos C, Bleiweiss I. J, Drossman S, Tartter P. I. Breast cancer in an intramammary sentinel node. Breast J. 2001; 7: 260-262.10.1046/j.1524-4741.2001.98106.x
- 18. Vijan S. S, Hamilton S, Chen B, Reynolds C, Boughey J. C, Degnim A. C. Intramammary lymph nodes: Patterns of discovery and clinical significance. Surgery. 2009; 145: 495-499.10.1016/j.surg.2009.01.015
- 19. Cox C. E, Cox J. M, Ramos D, Meade T. L. Intramammary sentinel lymph nodes: what is the clinical significance? Ann Surg Oncol. 2008; 15: 1273-1274.
- 20. Krag D. N, Anderson SJ, Julian TB, et al. Sentinellymph- node resection compared with conventional axillary-lymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncology. 2010; 11(10): 927-933.10.1016/S1470-2045(10)70207-2
- 21. Giuliano A. E, Hunt K. K, Ballman K. V, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2011; 305(6): 569-575.10.1001/jama.2011.90538985721304082
- 22. Chen S. L, Iddings D. M, Scheri R. P, Bilchik A. J. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA: A Cancer Journal for Clinicians. 2006; 56(5): 292-309.10.3322/canjclin.56.5.29217005598